Defining human mesenchymal stem cell efficacy <it>in vivo</it>
<p>Abstract</p> <p>Allogeneic human mesenchymal stem cells (hMSCs) can suppress graft versus host disease (GvHD) and have profound anti-inflammatory and regenerative capacity in stroke, infarct, spinal cord injury, meniscus regeneration, tendinitis, acute renal failure, and heart d...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-10-01
|
| Series: | Journal of Inflammation |
| Online Access: | http://www.journal-inflammation.com/content/7/1/51 |